Management of invasive candidal infections: results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature.
about
Amphotericin B versus fluconazole for controlling fungal infections in neutropenic cancer patientsInterventions for treating oral candidiasis for patients with cancer receiving treatmentInterventions for treating oral candidiasis for patients with cancer receiving treatmentInterventions for treating oral candidiasis for patients with cancer receiving treatmentCandida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicansCurrent and emerging azole antifungal agentsPhase 2, randomized, dose-ranging study evaluating the safety and efficacy of anidulafungin in invasive candidiasis and candidemiaAmphotericin B vs fluconazole for controlling fungal infections in neutropenic cancer patients.Impact of an intravenous fluconazole restriction policy on patient outcomes.Fungal infection-related mortality versus total mortality as an outcome in trials of antifungal agents.Fluconazole for empiric antifungal therapy in cancer patients with fever and neutropeniaECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patientsThirteen-year evolution of azole resistance in yeast isolates and prevalence of resistant strains carried by cancer patients at a large medical center.Pharmacodynamics of fluconazole in a murine model of systemic candidiasis.The 1998 Garrod lecture. Current and future antifungal therapy: new targets for antifungal agents.Modulation of neutrophil function in host defense against disseminated Candida albicans infection in mice.Treatment of fungal infections in surgical patients using conventional antifungals.Systematic review and meta-analysis of the tolerability and hepatotoxicity of antifungals in empirical and definitive therapy for invasive fungal infection.Interaction between fluconazole and amphotericin B in mice with systemic infection due to fluconazole-susceptible or -resistant strains of Candida albicans.Emerging Issues in Nosocomial Fungal Infections.Candidal vertebral osteomyelitis: report of 6 patients, and a review.Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin or micafungin.Fluconazole in transplant recipients: options and limitations.A clinical perspective for the management of invasive fungal infections: focus on IDSA guidelines. Infectious Diseases Society of America.Commonly used antibacterial and antifungal agents for hospitalised paediatric patients: implications for therapy with an emphasis on clinical pharmacokinetics.Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?Clinical hepatotoxicity associated with antifungal agents.Delayed reimplantation arthroplasty for candidal prosthetic joint infection: a report of 4 cases and review of the literature.Treatment of documented and suspected neutropenia-associated invasive fungal infections.Management of invasive candidiasis in nonneutropenic ICU patients.Systemic antifungal therapy: new options, new challenges.The effects of renal impairment on the pharmacokinetics and safety of fosfluconazole and fluconazole following a single intravenous bolus injection of fosfluconazole.Pharmacokinetics of antifungal agents in children.Efficacy of caspofungin against invasive Candida or invasive Aspergillus infections in neutropenic patients.Update on management of infections in cancer and stem cell transplant patients.Triazole use in the nursery: fluconazole, voriconazole, posaconazole, and ravuconazoleCandida infections in the intensive care unit: epidemiology, risk factors and therapeutic strategies.Treatment of candiduria with micafungin: A case series.Economic evaluation of voriconazole for the treatment of candidemia in Canadian adults.Considerations in the approach to invasive fungal infection in patients with haematological malignancies.
P2860
Q24193785-ADEE79FC-F754-4D6F-BFD2-82D2218DE6E3Q24234207-5A051C62-E179-4E56-87FC-3C4C9C9A81B9Q24245511-4FF81A4D-8D93-40E9-9380-A47EFA54EA1FQ24247394-94C3DD1E-9B2C-4048-8DF4-9BF4C09E8339Q24550731-E314CEB7-64D9-434A-8477-C4CEF9A360DCQ24550733-DA510423-4269-4039-9E94-79BFD6E49120Q24563657-64E7EC91-5707-46D8-A28B-88C7B9DDD37DQ30887333-88EAFFE3-AB9E-42B7-917E-D34B09DB5E04Q31989784-C80F3925-39ED-481C-9788-CBAE269E1592Q33253851-0B5527D9-418C-435F-A427-6CA0EB6F14C3Q33265510-4B669D93-B3E6-438F-8B4F-69DF675C680BQ33573788-8766E16F-D93E-4606-8EFB-80B7D426DB8BQ33691981-13A064D4-186C-448D-A798-8182DB6731EAQ33695281-29D5C61C-02E1-4780-AB98-8001D1F3C7A9Q33726292-84DDF83C-CB15-47AB-8201-80497C9D7D22Q33780929-8A8063B8-BA9A-49EA-9E22-44A02222A136Q33840086-3594B0B2-3629-45A8-B09B-13FB1226BC50Q33876645-BBD520E2-4DA2-4C0E-B852-C9AD736A3DCEQ33978197-629D323B-4D05-4846-A905-6727F5AD2964Q34092228-60F4CC04-1FD2-4AEE-888B-1CAD57767F72Q34142007-906180AC-3C8C-423E-A990-04FD7DC30A56Q34228354-447A1A69-42ED-4259-B24D-E478B8F1E60AQ34294909-F49F2B94-64E0-426F-8AD5-6367F1A3EE77Q34335250-A02612EF-5186-44DB-9514-A485E7A688DDQ34437719-70622E64-F33D-43A1-A079-5599EF632E2AQ34490092-CE12D19D-CD82-423D-A1C8-65E6F85EB7E8Q34546811-35731F34-A7C7-4E64-9B8F-A561C5F432F9Q34553517-2E2432C7-DD0B-404D-A6F8-1B84A632E3A3Q34590013-A61183A5-3B27-4E24-8CF5-B1DF3871F8CFQ35122093-74499647-51E0-4E15-8B84-EAF200FEF1B2Q35585219-02516A25-0980-459D-BF2E-683B54F4D967Q35826181-426B6960-B396-4FC3-9E45-03677B6640E2Q36163345-8330F215-14CA-4195-BFCF-5865257690C3Q36341374-10E8EE7A-8202-48F4-A1E7-021FF69DAF0BQ36419298-9BBA2708-9502-47E1-9DC5-8C976ABC272DQ36521993-DF2E311F-BD39-41A6-ACBA-138ADF7E3E57Q36670916-2C9FC8A3-E980-4FCA-ACE9-8EA5BC178898Q36871028-03D20ED8-EA74-4A25-A04B-2EE105735579Q37021364-B86DB8E5-2902-4C34-9C52-19D7783BAF7EQ37049537-BDD53DF0-AFDD-49CB-993A-4E7DF5E2D9BA
P2860
Management of invasive candidal infections: results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Management of invasive candida ...... and review of the literature.
@en
type
label
Management of invasive candida ...... and review of the literature.
@en
prefLabel
Management of invasive candida ...... and review of the literature.
@en
P2093
P356
P1476
Management of invasive candida ...... and review of the literature.
@en
P2093
Abi-Said D
Anaissie EJ
Darouiche RO
Kontoyiannis DP
Williams T
P304
P356
10.1093/CLINIDS/23.5.964
P407
P577
1996-11-01T00:00:00Z